Concord Drugs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 605306, "name": "Concord Drugs", "stock_name": "Concord Drugs", "full_name": "Concord Drugs Ltd", "name_url": "stocks-analysis/concord-drugs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "73.82", "chg": 2.61, "chgp": "3.67%", "dir": 1, "prev_price": "71.21", "mcapval": "97.00 Cr", "mcap": "Micro Cap", "scripcode": 538965, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE858L01010", "curr_date": "Aug 10, 03:30 PM", "curr_time": "04:38 AM", "last_traded_at": "Aug 10, 03:30 PM IST", "bse_nse_vol": "7.35 k", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-drugs-605306-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Concord Drugs Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-concord-drugs-ltd-4136320", "imagepath": "", "date": "2026-08-04 23:18:22", "description": "The next results date for Concord Drugs Ltd is scheduled for 10 August 2026...." }, { "title": "Concord Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-drugs-ltd-is-rated-sell-by-marketsmojo-4132354", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ConcordDrugsLtd_mojoScore_4132354.png", "date": "2026-08-02 10:10:16", "description": "Concord Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Concord Drugs Ltd Edges Down 0.10% Amid Death Cross and Downgrade Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-ltd-edges-down-010-amid-death-cross-and-downgrade-signals-4120956", "imagepath": "", "date": "2026-07-26 10:00:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Stock opens at Rs.68.25, declines 2.60%</p>\n <p><strong>21 Jul:</strong> Sharp rebound to Rs.71.52 (+4.79%) on strong volume</p>\n <p><strong>22 Jul:</strong> Death Cross formation signals bearish trend; stock closes Rs.71.35 (-0.24%)</p>\n <p><strong>24 Jul:</strong> Week ends at Rs.70.00, down 1.49% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.68.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">R..." }, { "title": "Concord Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-ltd-forms-death-cross-signalling-potential-bearish-trend-4116538", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ConcordDrugsLtd_dealthcross_4116538.png", "date": "2026-07-22 18:10:22", "description": "Concord Drugs Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average, signalling a potential shift towards a bearish trend. This development raises concerns about the stock's medium to long-term momentum amid deteriorating technical and fundamental metrics." }, { "title": "Concord Drugs Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-drugs-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4114608", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ConcordDrugsLtd_mojoScore_4114608.png", "date": "2026-07-22 08:12:04", "description": "Concord Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 July 2026. This revision reflects a complex interplay of factors across quality, valuation, financial trends, and technical indicators, despite the company’s recent strong quarterly performance and notable stock price appreciation over the past year." }, { "title": "Concord Drugs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-drugs-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financial-performance-4105799", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ConcordDrugsLtd_mojoScore_4105799.png", "date": "2026-07-17 08:04:26", "description": "Concord Drugs Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and a strong quarterly financial performance. The upgrade, effective from 16 July 2026, is underpinned by positive shifts across quality, valuation, financial trends, and technical parameters, signalling a cautious but optimistic outlook for this pharmaceuticals micro-cap." }, { "title": "Concord Drugs Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-drugs-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4097873", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ConcordDrugsLtd_mojoScore_4097873.png", "date": "2026-07-13 08:04:53", "description": "Concord Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 10 July 2026. This revision reflects a complex interplay of deteriorating technical indicators, modest financial trends, and valuation considerations, despite a recent surge in quarterly profitability. Investors are advised to carefully weigh these factors amid the stock’s recent underperformance relative to benchmarks." }, { "title": "Concord Drugs Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-drugs-ltd-is-rated-hold-4093430", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ConcordDrugsLtd_mojoScore_4093430.png", "date": "2026-07-08 10:10:56", "description": "Concord Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Concord Drugs Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-drugs-ltd-is-rated-hold-4074956", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordDrugsLtd_mojoScore_4074956.png", "date": "2026-06-27 10:10:34", "description": "Concord Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 298, "sid": "605306", "stock_news_url": "https://www.marketsmojo.com/news/concord-drugs-605306" }, "announcements": [ { "caption": "Board Meeting Intimation for Quarterly Results", "datetime": "03-Aug-2026", "details": "Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Quarterly Results", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "13-Jul-2026", "details": "Certificate under Reg 74(5) of SEBI (DP) Regulations", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "25-Jun-2026", "details": "Closure of Trading Window", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Jul: Stock opens at Rs.68.25, declines 2.60%

21 Jul: Sharp rebound to Rs.71.52 (+4.79%) on strong volume

22 Jul: Death Cross formation signals bearish trend; stock closes Rs.71.35 (-0.24%)

24 Jul: Week ends at Rs.70.00, down 1.49% on the day

Read full news article

Concord Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-07-22 18:10:22

Concord Drugs Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average, signalling a potential shift towards a bearish trend. This development raises concerns about the stock's medium to long-term momentum amid deteriorating technical and fundamental metrics.

Read full news article

Concord Drugs Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-07-22 08:12:04

Concord Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 July 2026. This revision reflects a complex interplay of factors across quality, valuation, financial trends, and technical indicators, despite the company’s recent strong quarterly performance and notable stock price appreciation over the past year.

Read full news article

Concord Drugs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Performance

2026-07-17 08:04:26

Concord Drugs Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and a strong quarterly financial performance. The upgrade, effective from 16 July 2026, is underpinned by positive shifts across quality, valuation, financial trends, and technical parameters, signalling a cautious but optimistic outlook for this pharmaceuticals micro-cap.

Read full news article

Concord Drugs Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-07-13 08:04:53

Concord Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 10 July 2026. This revision reflects a complex interplay of deteriorating technical indicators, modest financial trends, and valuation considerations, despite a recent surge in quarterly profitability. Investors are advised to carefully weigh these factors amid the stock’s recent underperformance relative to benchmarks.

Read full news article

Concord Drugs Ltd is Rated Hold

2026-07-08 10:10:56

Concord Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Concord Drugs Ltd is Rated Hold

2026-06-27 10:10:34

Concord Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article